An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone with a recent tibial plateau fracture (a break near the top of the shin bone) wrote that they started using two experimental peptides, BPC-157 and TB-500, a few days after their injury and then discovered a blood clot in their thigh. They were put on a blood thinner (anticoagulant) after the clot was found. The snippet doesn’t say exactly where they got the peptides, what doses they used, or whether doctors think the peptides caused the clot. BPC-157 and TB-500 are short chains of amino acids called peptides. Think of them as tiny, simplified proteins that some people use because lab studies and anecdotal reports suggest they might speed healing of tendons, muscles, and other tissues. BPC-157 is derived from a protein in the stomach and is often claimed to help gut and soft-tissue repair. TB-500 is a synthetic version of a piece of a natural protein called thymosin beta-4 and is marketed for reducing inflammation and improving wound healing. Neither is an approved medicine for these uses in most countries, and quality and purity can vary a lot when bought online. What the available science actually shows is limited. Most of the published work on these peptides is in animals or in cell cultures, not large human trials. That means there’s some laboratory and animal evidence they can promote aspects of tissue repair, but that doesn’t prove they’re safe or effective in people. For the situation in the snippet, there is no clear, reliable evidence that BPC-157 or TB-500 cause blood clots in humans. The person’s clot could be related to the fracture, immobilization (not walking for weeks raises clot risk), or other medical factors. The post doesn’t provide enough detail to link the peptides to the clot definitively. Why this matters: people recovering from major leg injuries already have a higher risk of dangerous blood clots because they’re often immobile and have damaged tissue and blood vessels. Adding unregulated substances introduces uncertainty. If you’re recovering from a fracture, you and your medical team need to weigh proven strategies (like using recommended blood thinners when indicated, moving as soon as allowed, compression stockings) rather than assuming an experimental peptide will speed recovery or is harmless. Anyone thinking about using peptides after an injury should tell their doctor first, especially if they’re going to be immobilized or have other clot risks. Caveats and risks: neither BPC-157 nor TB-500 are approved drugs for healing injuries, so dosing, purity, effects and side effects aren’t well-established. Possible risks include infection from injections, allergic reactions, and unknown interactions with prescription medicines like blood thinners. In people with fractures who are at risk for clots, medical teams sometimes prescribe anticoagulants; combining those with unstudied substances could be dangerous or change how the medicines work. If you or someone else is in this situation, stop any unapproved injections and discuss them with the treating physician immediately so the care team has full information. Bottom line: these peptides are experimental and not a proven fix for fractures, and a blood clot after a leg break is a serious issue that should be managed by doctors using established treatments.
Source: r/Peptides